Author: Durian

Over 100,000 registrations received from nurses across 199* countries - a 28% increase from the third edition, which received 78,000+ registrations.One of the shortlisted Top 10 finalists will be honoured with the grand title award and a prize of USD 250,000.These finalists were selected following a rigorous evaluation process, led by esteemed expert jury and grand jury panels. The entire process is independently moderated by the appointed "Process Advisors" Ernst & Young LLP.DUBAI, May 8, 2025 - (ACN Newswire via SeaPRwire.com) - Aster DM Healthcare has today announced the Top 10 finalists for the fourth edition of Aster Guardians Global Nursing Award - a prestigious global recognition with USD 250,000 prize money, that honours the exceptional contributions of nurses worldwide. These 10 finalists were selected from a record-breaking pool of 100,000+ registrations across 199* countries, through a stringent evaluation process led by expert jury and Grand jury panels members. The entire process is independently moderated by the appointed "Process Advisors" Ernst & Young LLP.The top 10 finalists for 2025 includes: Catherine Maree Holliday (Centre for Community-Driven Response, Switzerland), Edith Namba (Mount Hagen Provincial Hospital, Papua New Guinea), Fitz Gerald Dalina Camacho (Mediclinic City Hospital, UAE), Dr. Jed Ray Gengoba Montayre (The Hong Kong Polytechnic University, Hong Kong SAR), Dr. Jose Arnold Tariga (Insight Global Health, USA), Khadija Mohamed Juma (Tudor Subcounty Hospital, Kenya), Maheswari Jaganathan (Cancer Research Malaysia), Naomi Oyoe Ohene Oti (Korle-Bu Teaching Hospital, Ghana), Dr. Sukhpal Kaur (PGIMER, India), Vibhaben Gunvantbhai Salaliya (Hospital for Mental Health, India). To know more about the top 10 finalists, please visit: https://www.asterguardians.com/Dr Azad Moopen, Founder Chairman, Aster DM Healthcare, said "The Top 10 finalists have demonstrated extraordinary dedication, skill, and compassion in their work - selected from over 100,000 registrations that were received for the 4th edition of Aster Guardians Global Nursing Award. These nurses are not just healthcare providers, but true leaders, pushing boundaries and making a profound impact in their communities. Their exceptional contributions deserve to be recognized, and through this award, we celebrate their passion and commitment to improving lives across the globe."The fourth edition of the Aster Guardians Global Nursing Award will not only present the grand prize of USD 250,000 to the winner, but also honour the other nine finalists with recognition and rewards. The final round will feature interviews with distinguished members of the Grand Jury, including: Prof. Sheila Tlou, Co-Chairperson of the Global HIV Prevention Coalition and Special Ambassador of the African Leaders Malaria Alliance, Botswana; Prof. James Buchan, Adjunct Professor at the WHO Collaborating Centre, University of Technology, Sydney, and Editor Emeritus of the Human Resources for Health Journal; Dr. Peter Carter, OBE Awardee and Independent Healthcare Consultant, Former CEO of Central & Northwest London NHS and Former CEO of the Royal College of Nursing, UK; Dr. Niti Pall, President-Elect at the International Diabetes Federation, Senior Consultant at AXA EssentiAll, France, and Board Chair of Harbr & Managing Director of Health4all Advisory, UK; and Mr. Vishal Bali, Executive Chairman of Asia Healthcare Holdings, Senior Advisor at TPG Growth, and General Council Member of the Neonates Foundation of India.The final stage will involve public voting and interviews with distinguished members of the Grand Jury, with the winner set to be announced at a gala event in Dubai, UAE on May 26, 2025. *As per data.worldbank.org/countryAbout Aster DM Healthcare FZC in GCCFounded in 1987 by Dr. Azad Moopen, Aster DM Healthcare is a leading integrated healthcare provider, with a strong presence across 5 countries in the GCC and Jordan. Aster is committed to the vision of providing accessible and high quality healthcare, from primary to quaternary services, with its promise of "We will treat you well". The organisation's robust integrated healthcare model includes 15 hospitals, 122 clinics, and 313 pharmacies in GCC serving all segments of the society through three differentiated brands: Aster, Medcare and Access. Aster consistently adapts to meet the evolving needs of patients, ensuring access to quality healthcare through both physical and digital channels which is exemplified with the launch of the region's first healthcare super app, myAster.About Aster DM Healthcare Limited, IndiaAster DM Healthcare Limited is one of the largest healthcare service providers operating in India with a strong presence across primary, secondary, tertiary, and quaternary healthcare through 19 hospitals with 5,128 beds, 13 clinics, 203 pharmacies (Operated by Alfaone Retail Pharmacies Private Limited under brand license from Aster), and 254 labs and patient experience centers across 5 states in India, delivering a simple yet strong promise to different stakeholders: "We'll Treat You Well."For more information about us, please contact:Lavanya MandalHead of PR and Internal CommunicationsAster DM HealthcareTel: +971 528126577Email: lavanya.mandal@asterdmhealthcare.com Udhayan Sasidharan NairManager - PR & CommunicationsAster DM HealthcareTel: + 971 508850520Email: udhayan.nair@asterdmhealthcare.com Annexure / Editor's Note -The top 10 finalists for 2025 include:Catherine Holliday, Centre for Community-Driven Response, Switzerland: Catherine Holliday founded the Centre for Community-Driven Response (CCDR) to embed patient experience as a core pillar of health policy, alongside clinical and economic evidence. Through the creation of the PEEK (Personal Experience, Expectations, and Knowledge)protocol, she has built one of the world's largest repositories of patient experience data - over 2,000 interviews shaping strategies across countries and ensuring patients become active hosts in their own care. Catherine also pioneered the Pathways Specialist Nurse Service, a nurseled Telehealth model delivering triage, assessment, and education to underserved, crisis-affected, and remote communities. Her model redefined Telehealth in nursing, expanding access for people with disabilities, mental health conditions, and chronic diseases in low-resource settings. Catherine was named one of the WHO's 100 Outstanding Women Nurses and Midwife Leaders (2020), received the Australian Health Minister's Award for Nursing Trailblazers (2022), and was honored with the President's Award for Legacy Contribution by the Australian Primary Health Care Nurses Association (2024).Edith Namba, Mount Hagen Provincial Hospital, Papua New Guinea: Edith Namba is a courageous nursing leader whose 27-year journey has been instrumental in advancing patient care, spearheading public health initiatives, and specializing in gender-based violence response programs. Triggered by the urgent needs she witnessed during cholera outbreaks and gender-based violence crisis, Edith has led systemic change - pioneering emergency care for survivors, playing a crucial role in piloting Family Support Centres in rural areas, and training health workers to provide holistic care. Edith has also received recognition from CIMC for her work of volunteerism in the fight against of Gender based Violence in Papua New Guinea. Her initiatives have reduced preventable harm, advanced gender equity, and redefined what it means to lead in healthcare - not from behind a desk, but at the heart of crisis and community.Fitz Gerald Dalina Camacho, Mediclinic City Hospital, UAE: Fitz Gerald Dalina Camacho is a nurse educator whose journey was ignited by a deep conviction that safe, high-quality care begins with empowered, well-trained nurses. Fitz has played a key role in enhancing safety protocols and education systems across hospitals in the Middle East. His initiatives include the establishment of the Life Support Training Center in collaboration with the American Heart Association, the design and launch of the Continuous Medical Education (CME) Program, and the development of Adult and Pediatric Nursing Upskilling Programs. These efforts combine hands-on innovation with global standards. Fitz's passion for equity also extends beyond the hospital, as he actively teaches and volunteers with underserved communities.Dr. Jed Ray Gengoba Montayre,Centre for Evidence-Based Practice for Healthcare Policy, The HongKong Polytechnic University, Hong Kong SAR: Dr. Jed Ray Gengoba Montayre is a globally recognised Gerontologist, Researcher and Policy Influencer whose work drives systems-level change in ageing, caregiver support, and the global nursing workforce. He has led multiple World Health Organization commissioned projects, including a global review of community-based age-friendly interventions that informed the WHO Age-Friendly Framework, and a critical analysis of strategies to improve science literacy during public health emergencies. His pioneering contributions to nursing education - such creation of an interdisciplinary program Master of Ageing, Wellbeing, and Sustainability - has redefined how future health leaders are trained. Dr. Montayre's research and digital innovations, including telecare for socially isolated older adults, continue to shape inclusive, evidence-based care across borders. His contributions have earned him numerous accolades, including the prestigious "Distinguished Educator in Gerontological Nursing" award from the U.S.-based National Hartford Center of Gerontological Nursing Excellence in 2021. He was also honoured with the "Vice-Chancellor Excellence in Research" award for Early Career Research at Western Sydney University in 2022 and named "New Zealand Young Nurse of the Year" in 2016.Dr. Jose Arnold Tariga, Insight Global Health, USA: Dr Jose Arnold Tariga is a transformative nursing educator and global health advocate whose mission was sparked by his own early struggles navigating bias as a highly qualified, non-western trained nurse entering the U.S. healthcare system. Turning adversity into action, he developed the groundbreaking International Transition to Practice Program (ITPP), a model now shaping how internationally educated nurses bridge clinical, cultural, and communication gaps. From designing rapid upskilling modules during COVID-19 to challenging systemic inequities in nursing education, his work has elevated standards, improved retention, and expanded access. Prior to his move to the USA, he spent over 9 years in the UAE driving education and training for staff at multiple organizations, delivering lectures and workshops recognized by the Department of Health.Khadija Mohamed Juma, Tudor Subcounty Hospital, Kenya: Khadija Mohamed Juma is a Kenyan nurse and social innovator revolutionizing blood donation access through her tech-enabled platform, RedSplash. In just five years, she has led over 500 blood donation campaigns, collected more than 25,000 units of blood, and saved an estimated 75,000 lives -transforming Kenya's approach to emergency care. Recognized by the Commonwealth Youth Awards and featured on global media, Khadija's Smart Donor Search app connects donors to patients in real time, all while breaking cultural taboos and mobilizing over 500 volunteers. Her bold, community-driven approach is redefining the future of healthcare accessibility in Africa.Maheswari Jaganathan, Cancer Research Malaysia: Maheswari Jaganathan is a nationally recognized oncology nurse leader who pioneered Malaysia's Patient Navigation Program, which has transformed breast cancer care by reaching over 4,700 newly diagnosed women and closing critical gaps in access and equity. This program -now implemented across multiple hospitals in Malaysia-integrates clinical support with financial, legal, and emotional advocacy, dramatically improving patient outcomes. Recognized by the World Health Organization, her work is redefining nursing as a force for system change. She plans to set up a Navigation Academy for Southeast Asia - a regional hub of learning and collaboration focused on system change, AI, mHealth, and research, further positioning nurses at the forefront of healthcare transformation.Naomi Oyoe Ohene Oti, Korle-Bu Teaching Hospital, Ghana: Naomi Oyoe Ohene Oti is a nationally and internationally recognized oncology nurse leader and recipient of multiple honours for her contributions to cancer care, research, and education in Africa. She played a crucial role in the setting up a formal oncology nurse training program in Ghana. Through her leadership, the centre had trained over 60 oncology nurse specialists and 10 breast care nurses. She is a member of education and training committee for the African Organisation for Research and Training in Cancer (AORTIC), and coinvestigator on Global Bridges Oncology GM Grant, she has shaped continental competencies and policies in cancer nursing, while mentoring more than 48 nurses from African nations. Her initiatives in driving nurse-led education and research - are revolutionizing cancer care and positioning nursing as a central force in Africa's cancer control response.Dr Sukhpal Kaur, PGIMER, India: Dr. Sukhpal Kaur is a pioneering force in Indian nursing whose 34-year career has redefined how evidence-based care reaches the most vulnerable. Motivated by the urgent need for nurse-led innovation in underserved settings, she played a key role in securing national interdisciplinary research grants - developing mobile apps, home-care protocols, and indigenous therapies that have improved outcomes for cancer patients, bedridden elders, and rural families. From contributing to nurse-led specialty clinics to transforming education through simulation and competency based learning, her work bridges academic excellence with grassroots impact - making compassionate, research-driven care accessible where it's needed most.Vibha Salaliya, Hospital for Mental Health, India: Vibha Salaliya is a nationally recognized mental health nurse and recipient of the Florence Nightingale Award. She has been instrumental in implementation of the Peer Support Volunteer (PSV) model, which has now scaled across four government mental hospitals in Gujarat. Through this revolutionary initiative, over 3000 individuals with mental illness have achieved economic independence, and 426 patients have transitioned from care receivers to care givers-breaking the stigma and cycle of institutionalization. Her clinical innovations have drastically reduced hospital stay durations from 90 to 43 days by integrating psychotherapeutic approaches, life skills training, family reintegration strategies, and vocational rehabilitation initiatives. She has also trained over 6000 frontline professionals across Gujarat.SOURCE: Aster DM Copyright 2025 ACN Newswire via SeaPRwire.com.

SAN RAMON, CA, May 8, 2025 - (ACN Newswire via SeaPRwire.com) - Sensiba LLP, ranked among the Top -75 U.S. accounting and consulting firms, is pleased to announce the addition of six new partners to its ownership group, effective May 1, 2025.This milestone marks the largest single-year partnership expansion in Sensiba's history and reflects the firm's international growth, including its recent acquisition of cybersecurity audit and risk assurance firm AssuranceLab. The move also underscores Sensiba's continued focus on delivering forward-thinking, technology-enabled services to clients across dynamic markets.The firm's partner group now includes 30 leaders, nearly half of whom are women, significantly exceeding the accounting industry's average and reinforcing Sensiba's commitment to diversity and leadership equity."We're proud to welcome this outstanding group of professionals to our partnership," said Managing Partner John Sensiba. "They've all shown an unwavering commitment to our clients, our colleagues, and the communities we serve. Their leadership will help drive our focus on tech-enabled innovation as we work with clients to navigate their evolving security and compliance challenges across dynamic markets."Introducing Sensiba's New Partners:Scott Dritz - As a Risk Assurance Partner, Scott Dritz helps clients strengthen their cybersecurity posture and streamline ISO compliance. His leadership expands Sensiba's risk assurance capabilities and supports organizations navigating today's complex security landscape.Masha Herzbrun - Tax Partner Masha Herzbrun advises venture capital and technology clients on tax compliance and strategic planning. She brings specialized expertise in tax issues for startups and investors across complex corporate, federal, and state tax matters, including the compliance implications of cryptocurrencies. She also advises individuals who are general partners or owners of venture capital and technology clients on tax compliance.Natela Katamadze - Audit Partner Natela Katamadze focuses on serving clients across the venture capital sector, supporting investment entities from emerging funds to established multi-fund entities. Her areas of expertise include fund of funds, real estate investments, and digital asset investments, including complex fund structures, allocation methodologies, and valuations.Lexie Ling - Tax Partner Lexie Ling specializes in venture capital partnership taxation, international tax compliance, and multi-state strategies. She has extensive experience serving venture capital funds and fund of funds. She works closely with partnerships and high net worth individuals to develop forward-looking tax solutions that support long-term growth and compliance.Nicholas Lew Ton - Partner Nicholas Lew Ton drives Sensiba's enhancements to client experience and service delivery. As Cofounder and former Co-CEO of AssuranceLab, he has built high-performing teams and guided hundreds of SaaS and cloud technology clients through compliance journeys. He is known for aligning teams around shared goals and modernizing how firms deliver client service at scale.Paul Wenham - Partner Paul Wenham leads Sensiba's innovation strategy and supports the firm's continued strategic growth. As Cofounder and former Co-CEO of AssuranceLab, he pioneered the development of modern, client-centered cybersecurity audits and compliance solutions, blending smarter systems with human-centered design.About SensibaSensiba's global accounting, tax, risk assurance, and consulting services help businesses and people solve problems, establish trust, and build a foundation for sustainable growth. As an independent, partner-owned firm ranked among the Top 75 U.S. accounting and consulting firms, Sensiba serves clients throughout North America, APAC, and EMEA. We're passionate about collaborating with clients to increase efficiency, mitigate risk, and embrace emerging opportunities. As a certified B Corp, we foster a culture where people, families, and communities thrive. As a member of Morison Global, we support our clients' international accounting and tax needs. For more information, visit Sensiba.com.CONTACT:Marc Stevens, Brand & Communications Manager925-271-8700 x7166mstevens@sensiba.comSOURCE: Sensiba LLP Copyright 2025 ACN Newswire via SeaPRwire.com.

JAKARTA, May 7, 2025 - (ACN Newswire via SeaPRwire.com) - The construction industry is under pressure by challenging global economic conditions. This is reflected by new contracts secured by PT Wijaya Karya (Persero) Tbk (WIKA) of only Rp2.16 trillion, which is lower compared to the same period the previous year. However, the Company booked Rp4.84 trillion in sales, comprising Rp3.11 trillion from non-joint operation projects (Proyek Non-Kerjasama Operasi) and Rp1.73 trillion from joint operation projects (Proyek Kerjasama Operasi, “KSO”).Sales were mainly generated from the building and infrastructure segment, EPC, construction-related industries, and real estate property. The sales achievement enabled WIKA to book a gross profit of Rp393.46 billion, of which Rp231.33 billion came from non-KSO projects and the remainder from KSO projects.WIKA’s consistent restructuring efforts have successfully reduced debts on its balance sheet to financial institutions and business partners by Rp1.47 trillion in Q1-2025 compared with 2024.These positive achievements were also followed by proposals that were approved by bondholders, especially for the Wijaya Karya Shelf Registration Bond II Phase II Year 2022. This reflects stakeholders’ support for the Company’s ongoing restructuring plans. As a result of the approval, the credit rating agency, PT Pemeringkat Efek Indonesia (PEFINDO), upgraded WIKA’s Shelf Registration Bond II Phase II Year 2022 Series A rating from idD to idCCC. However, the Company must seek support from sukukholders of the Wijaya Karya Shelf Registration Sukuk Mudharabah II Phase II Year 2022 to approve the proposals presented, which are part of the Company’s restructuring plans.“The Company expresses its deepest appreciation for the trust and support given by stakeholders. The ongoing restructuring plans are not only focused on improving our financial structure but also on strengthening our fundamentals and operations to attain greater excellence and maintain business sustainability,” said Agung BW, President Director of WIKA.PT Wijaya Karya (Persero) Tbk. [IDX: WIKA]Contact: Mahendra VijayaSekretaris PerusahaanEmail: mahendra.v@wikamail.id Copyright 2025 ACN Newswire via SeaPRwire.com.

ANTWERPEN, BELGIUM, May 6, 2025 - (ACN Newswire via SeaPRwire.com) - OMP, a global leader in supply chain planning solutions, has achieved four second-highest scores across five Use Cases, evaluated in the 2025 Gartner® Critical Capabilities for Supply Chain Planning Solutions report. This report, a companion to the Gartner Magic Quadrant™, assesses the vendors of the SCP solutions evaluated in this research.This recognition follows OMP's recent position as highest on the Ability to Execute axis in the 2025 Gartner Magic Quadrant for Supply Chain Planning Solutions - marking the tenth consecutive time OMP is named a Leader.Consistent strength across real-world planning challengesThe Critical Capabilities report evaluates 20 vendors on 15 key capabilities across five SCP Use Cases. We believe OMP's scores, particularly in supply planning, decision/plan alignment, and the breadth of resource types, demonstrate its strong performance in these critical areas."Supply chains today need real solutions that deliver measurable impact, and this report validates our ability to do just that," says Philip Vervloesem, Chief Commercial & Markets Officer at OMP. "Unison Planning™ stands out in end-to-end multi-enterprise planning and decision/plan alignment, two capabilities essential in today's fast-moving landscape. It enables smart, fast, and unified decision-making in complex environments."Unison PlanningTM: enabling real-time, data-driven decisionsOMP's Unison Planning™ is an open, cloud-native, and AI-driven platform that supports supply chain planning across all layers, from strategic to operational, and from supply to demand. Designed for agility and resilience, it enables real-time collaboration, optimization, and response."By embedding generative AI and explainable AI (XAI) into every layer of the platform - from data-driven forecasting to scenario management - we empower planners to adapt with speed and intelligence," adds Tom Wouters, Chief Product Officer at OMP."Proven performance, global trust"We believe recognition in both the Magic Quadrant and the Critical Capabilities reports underscores our ability to execute and to deliver real business value," concludes Kurt Gillis, Chief Industry & Commercial Officer at OMP. "It reflects our deep industry expertise, which allows us to develop real solutions for industry-specific challenges. We're proud to help global leaders across industries turn complexity into a competitive edge."Gartner, Critical Capabilities for Supply Chain Planning Solutions, Pia Orup Lund, et. Al, 14 April 2025.Gartner, Magic Quadrant for Supply Chain Planning Solutions, Pia Orup Lund, et. Al, 14 April 2025Gartner and Magic Quadrant are registered trademarks of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved.DisclaimerGartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.Contact InformationPhilip VervloesemChief Commercial & Markets Officerpvervloesem@omp.com+1-770-956-2723SOURCE: OMP Copyright 2025 ACN Newswire via SeaPRwire.com.

LONDON, May 6, 2025 - (ACN Newswire via SeaPRwire.com) - A new report released today by the World Hepatitis Alliance (WHA) reveals widespread knowledge gaps, inequities in access, and critical systemic barriers impeding the global fight against hepatitis delta.Also known as hepatitis D, hepatitis delta is a severe liver disease affecting an estimated 12 million people worldwide. It occurs in people living with hepatitis B, leads to faster disease progression, and significantly increases the risk of liver cancer and death.The Hepatitis Delta Global Landscape Survey collected responses from 583 individuals across 102 countries, providing the most comprehensive picture to date of global stakeholder perspectives on awareness, testing, and treatment access around hepatitis delta.Key Findings:There are pronounced regional variations in reported availability and accessibility of hepatitis delta testing and treatment.Even where hepatitis delta testing and treatment are reported to be available, accessibility remains a significant challenge.Both direct and indirect costs are reported as considerable barriers to equitable access to hepatitis delta treatment and care.There are pronounced gaps in knowledge and awareness of hepatitis delta reported by all stakeholders with pronounced regional variations.Lack of knowledge is reported as the most common barrier to both testing and treatment.A third of respondents did not feel sufficiently informed to identify the barriers to hepatitis delta testing and treatment.HCPs reported low levels of training around hepatitis delta, and most expressed a clear interest in further education."These findings highlight an urgent need for coordinated action to scale up hepatitis delta education, diagnosis, and care," said Cary James, CEO of WHA. "Without informed providers, empowered communities, and accessible health services, millions will remain undiagnosed and untreated."Calls to Action:Increase both availability and accessibility of testing and treatment for hepatitis delta in health systems.Address the issues of direct and indirect costs of testing and treatment to increase engagement by communities.Adopt testing policies to follow WHO recommendations on reflex testing for hepatitis delta.Inform people living with hepatitis B of the need to test for hepatitis delta through culturally competent awareness campaigns.Provide more robust training on hepatitis delta to healthcare professionals throughout their career progression.Increase provision of knowledge and awareness programmes for community-based organisations and policymakers.Implement skills-building programmes for community-based organisations so they can better advocate to policymakers and public health officials for greater access to testing, treatment and care.Download the full report: www.worldhepatitisalliance.org/hepatitis-d-surveyNote to Editors:For further information or interview requests contact: Cary James, Chief Executive, World Hepatitis AllianceEmail: contact@worldhepatitisalliance.orgAbout WHA:The World Hepatitis Alliance is an international network of 400 civil society and community organisations across more than 100 countries. It is dedicated to harnessing the power of people living with viral hepatitis to drive its elimination. At WHA, member organisations are the cornerstone of the alliance, working collaboratively to combat hepatitis through advocacy, capacity building, and awareness-raising efforts. WHA also holds countries accountable to their commitments to elimination, fostering action by partnering with a diverse range of organisations worldwide, from local civil society groups to ministries of health and global institutions. www.worldhepatitisalliance.orgSOURCE: World Hepatitis Alliance Copyright 2025 ACN Newswire via SeaPRwire.com.

JAKARTA, May 6, 2025 - (ACN Newswire via SeaPRwire.com) - PT WIJAYA KARYA (Persero) Tbk (WIKA) continues to demonstrate its commitment to being a national construction company with business performance excellence as well as sustainability and social responsibility performance. In April 2025, WIKA received two prestigious awards: InvestorTrust’s “Best Corporate Emission Reduction Transparency Award 2025” and The Iconomics’ “7th Indonesia CSR Brand Equity Awards 2025” for the Construction category.The ”Best Corporate Emission Reduction Transparency Award 2025” was convened at the Sultan Hotel in Jakarta on Tuesday, 29 April 2025. The award was presented to companies that actively contributed towards national and global decarbonization efforts. WIKA was one of 95 selected awardees for its transparency and commitment to reporting and managing carbon emissions. Of the 370 companies nominated, WIKA was selected for having fulfilled the key criteria, including the timely release of the 2023 Sustainability Report, transparent emission declarations, and compliance with environmental governance principles without any serious legal conflicts.On the same day, WIKA received another award in the “7th Indonesia CSR Brand Equity Awards 2025”, which was presented by The Iconomics dan Axia Research held at the Ministry of Transportation building. The event carried the theme “Developing Brand Companies with Government’s CSR Goals.” It served as a platform to recognize companies that have built strong and effective brand identities through CSR initiatives aligned with national development objectives. WIKA was recognized to have consistently incorporated sustainability values into its business strategy. The Company also demonstrated a strong commitment to implementing social responsibility programs that have a genuine impact on the environment and society.“We believe a company’s success is determined not only by its financial performance but also by the good impact that it has on society and the environment. These two awards serve as motivation for everyone at WIKA to continue innovating and making meaningful contributions,” said Agung Budi Waskito (BW), President Director of WIKA.As an important partner in national development, WIKA continues its active role in sustainability through various initiatives, from implementing inclusive and targeted CSR programs to energy efficiency and carbon emission management. WIKA remains committed to developing a responsible business that delivers added value to all stakeholders.PT Wijaya Karya (Persero) Tbk. [IDX: WIKA]Contact:Mahendra VijayaSekretaris PerusahaanEmail: mahendra.v@wikamail.id Copyright 2025 ACN Newswire via SeaPRwire.com.

ADELAIDE, AUS, May 6, 2025 - (ACN Newswire via SeaPRwire.com) - With more than 30 years of executive experience in the property and investment sectors, Tom brings an extraordinary depth of expertise spanning office, retail, industrial, and residential asset classes. He has held senior leadership roles at several high-profile organizations, including CEO of Panda Global Funds, where he led operations across international markets, and as a senior specialist at Payton Capital, recently acquired by ASX-listed HMC Capital. He has also served as Senior Executive - Investments at Occasio Funds Management.Before joining Eastern River, Tom played a pivotal role in a number of corporate advisory and capital raising mandates across both domestic and international markets, with deep investor networks in the UAE, Asia, and the Americas. His global perspective and strategic insight will be instrumental in driving Eastern River's next phase of expansion.Tom has also served as a Non-Executive Director for several China-based companies seeking ASX listings, further demonstrating his unique capability in cross-border corporate structuring and capital markets. Beyond the boardroom, Tom holds equity positions across multiple businesses and investment entities in property development, construction, and venture capital. He holds an MBA and several professional diplomas in corporate and investment disciplines."Bringing Tom into the business is a landmark moment for Eastern River. His track record and depth of experience align perfectly with our long-term vision of becoming a leading force in the private investment and funds management sector," said Tekauri Ryan Hurst, CEO & Executive Director of Eastern River Pty Ltd.For media inquiries or interview requests, please contact:Mrs. Sally PetersPublic Relations OfficerEastern River Pty LtdEmail: media@easternriver.comWebsite: www.easternriver.comSOURCE: Eastern River Pty Ltd Copyright 2025 ACN Newswire via SeaPRwire.com.

VILNIUS, LT, May 5, 2025 - (ACN Newswire via SeaPRwire.com) - Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), today announced the expansion of its protein-based and gene therapy service offerings with the addition of Viral Clearance Studies (VCS) capabilities. This strategic growth follows the opening of Northway Biotech's new Gene Therapy Center with dedicated cGMP facilities for virus-related projects.With six newly established, identical BSL-2 laboratories now operational, Northway Biotech can conduct VCS programs for up to six clients simultaneously, significantly alleviating current market bottlenecks. Additionally, the company has expanded its capabilities to perform GMP-compliant manufacturing and testing under BSL-3 conditions, further strengthening its service offering across gene therapy and broader biologics development.Viral Clearance Studies are now offered both as part of Northway Biotech's integrated CDMO programs and as a standalone service. This flexibility allows external clients to access VCS expertise independently, without requiring a manufacturing agreement.Accelerated Delivery Timelines - Over One Month Faster Than IndustryLeveraging expanded infrastructure and integrated analytical capabilities, Northway Biotech is positioned to deliver Viral Clearance Studies substantially faster than the current industry standard. Comprehensive studies, assessing viral removal and inactivation, can now be completed with final regulatory-compliant reporting in under 10 weeks from initiation of project design when two model viruses are employed, and within 12 weeks when four model viruses are used."Our expansion into Viral Clearance Studies is a natural extension of our CDMO services, enabling us to manage these critical studies in-house and significantly reduce project timelines for our clients," said Prof. Vladas Algirdas Bumelis, CEO of Northway Biotech. "By investing in state-of-the-art BSL-2 and BSL-3 facilities, expanding technical capabilities, and further strengthening our scientific teams, we are uniquely positioned to deliver high-quality VCS data faster - a key advantage for clients advancing through clinical development and regulatory approval."For more information on Northway Biotech's Viral Clearance Study processes, service offerings, and delivery timelines, please complete the contact form to connect with the Northway Biotech team.About Northway Biotech - https://www.northwaybiotech.comNorthway Biotech is a leading contract development and manufacturing organization (CDMO) supporting customers worldwide. Its highly experienced and professional team executes projects at every stage, from cell line construction and process development to cGMP manufacturing of biopharmaceutical products. The company's extensive expertise and vertically integrated service offering enables rapid execution of multiple projects from its state-of-the-art GMP facilities while ensuring full process and product compliance at all stages of research, development, and commercial manufacturing. Northway Biotech is a privately owned company founded in 2004 and operates locations in Vilnius, Lithuania; London, United Kingdom; and Waltham, MA, USA.Media & Business Contact:bd@northwaybiotech.comProf. Vladas Algirdas BumelisCEO and Chairman of the BoardNorthway Biotechvladas.bumelis@northwaybiotech.comContact InformationVladas BumelisCEO and Chairman of the Boardvladas.bumelis@northwaybiotech.comSOURCE: Northway Biotech Copyright 2025 ACN Newswire via SeaPRwire.com.